Albumin Replacement Therapy Shows No Benefit in Septic Shock
Albumin replacement therapy targeting serum levels ≥ 3.0 g/dL does not improve 90-day survival in patients with septic shock in the emergency department, a trial shows. Medscape Medical News source https://www.medscape.com/viewarticle/albumin-replacement-therapy-shows-no-survival-benefit-septic-2026a10007qy?src=rss